Interferon alpha-2b biosimilar - Amega Biotech

Drug Profile

Interferon alpha-2b biosimilar - Amega Biotech

Alternative Names: Interferon Alfa-2b biosimilar - Amega Biotech

Latest Information Update: 23 Aug 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Amega Biotech
  • Class Antineoplastics; Antivirals; Interferons
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase Unknown Condylomata acuminata; Follicular lymphoma; Hairy cell leukaemia; Hepatitis C; Kaposi's sarcoma; Malignant melanoma

Most Recent Events

  • 14 Aug 2013 Investigation in Condylomata acuminata in Argentina (Parenteral)
  • 14 Aug 2013 Investigation in Follicular lymphoma in Argentina (Parenteral)
  • 14 Aug 2013 Investigation in Hairy cell leukaemia in Argentina (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top